Komlossy Law, P.A. Announces Investigation of Conceptus, Inc.

HOLLYWOOD, Fla.--(BUSINESS WIRE)--

Komlossy Law, P.A. is investigating the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) CPTS for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Bayer HealthCare LLC in a transaction valued at approximately $1.1 billion. Pursuant to the terms of the proposed transaction, Conceptus shareholders are to receive $31.00 in cash for each share.

The investigation involves whether the Board of Directors of Conceptus breached their fiduciary duties to stockholders by favoring the interests of certain officers and directors of the Company in the proposed acquisition, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Conceptus stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or Ross A. Appel, Esq. at raa@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation. Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm. More information is available through its website, www.komlossylaw.com/CPTS, and upon request from the firm. Emily C. Komlossy is the attorney responsible for the content of this release.

Attorney Advertisement. Past results do not guarantee or predict a similar outcome with respect to any future matter.